Consolidated guidelines on HIV testing services for a changing epidemic
27 November 2019
| Policy brief
Overview
These consolidated guidelines bring together existing and new evidence-based guidance and recommendations for delivering high-impact HIV testing services, including linkage to HIV prevention and treatment, in diverse settings and populations.
A key objective of these guidelines is to encourage greater national and global commitment to implementing effective and efficient HTS as a vital element of the national and global HIV response, essential to achieving and maintaining low HIV incidence.
Guidelines
Download
Chinese version (PDF, 440 KB)
Russian version (PDF, 1.2 MB)
Powerpoint presentation
- HTS guidelines: new guidance, recommendations and good practice - Part 1, PPT, 7.8MB
- HTS guidelines: new guidance, recommendations and good practice - Part 2, PPT, 7.9MB
Related policy briefs
- WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms
- WHO recommends social network-based HIV testing approaches for key populations as part of partner services package
- Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care
- What works for generating demand for HIV testing services
- WHO recommends HIV self-testing – evidence update and considerations for success
- WHO encourages countries to adapt HIV testing strategies in response to changing epidemic
Web annexes
- Annex A - GRADE Table: Which demand creation approaches are effective for increasing uptake of HIV testing and onward linkage to prevention, treatment and care? (PDF, 654 KB)
- Annex B - GRADE Table: Should HIV self-testing be offered as an additional HIV testing approach? (PDF, 619 KB)
- Annex C - GRADE Table: Should social network-based approaches be offered as an additional HIV testing approach for key populations and their contacts? (PDF, 437 KB)
- Annex D - GRADE Table: Should western blotting and line immunoassays be used in national testing strategies and algorithms? (PDF, 665 KB)
- Annex E - Abstract: Performance of HIV testing strategies: considerations for global guideline development (PDF, 299 KB)
- Annex F - Abstract: Modelling the cost-effectiveness of maternal HIV retesting in high- and low-HIV burden settings (PDF, 388 KB)
- Annex G - Abstract: Modelling the cost-effectiveness of using HIV/syphilis dual tests in antenatal care in high and low HIV burden settings (PDF, 240 KB)
- Annex H - Considerations for monitoring HIV testing services programmes (PDF, 253 KB)
- Annex I - In vitro diagnostics for HIV diagnosis (PDF, 313 KB)
- Annex J- Ensuring the quality of HIV testing services (PDF, 276 KB)
- Annex K - Global examples of HIV testing services (PDF, 1.7 MB)
- Annex L - Symptom and risk-based screening to optimize HIV testing services: a scoping review (PDF, 727 KB)
Editors
WHO
Number of pages
12
Reference numbers
WHO Reference Number: WHO/CDS/HIV/19.31
Copyright
